Hospira Gemcitabine for IV Infusion 200 mg

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Prenos Javno poročilo o oceni (PAR)
27-11-2017

Aktivna sestavina:

gemcitabine hydrochloride, Quantity: 45.54 mg/mL

Dostopno od:

Hospira Australia Pty Ltd

INN (mednarodno ime):

Gemcitabine hydrochloride

Farmacevtska oblika:

Injection, intravenous infusion

Sestava:

Excipient Ingredients: mannitol; sodium acetate trihydrate

Pot uporabe:

Intravenous Infusion

Enote v paketu:

1 X 10 mL vial

Razred:

Medicine Listed (Export Only)

Tip zastaranja:

(S1) This Schedule is intentionally blank

Terapevtske indikacije:

Non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Povzetek izdelek:

Visual Identification: A white to off white lyophilized powder in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Listed (Export Only)

Datum dovoljenje:

2013-01-07